Recombinant RSV (Palivizumab Biosimilar) 抗体
This anti-RSV (Palivizumab Biosimilar) antibody is a Humanized 单克隆 antibody detecting RSV (Palivizumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
Quick Overview for Recombinant RSV (Palivizumab Biosimilar) 抗体 (ABIN7795088)
抗原
RSV (Palivizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
单克隆
标记
This RSV (Palivizumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), In vivo Studies (in vivo)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Palivizumab Biosimilar, Endotoxin 0.05 EU/mg
-
产品特性
- Palivizumab, a humanized anti-RSV (respiratory syncytial virus) monoclonal antibody, targets an epitope in the A antigenic site of the F protein of RSV, inhibiting its entry into the cell and thereby preventing infection.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- Less than 0.5 EU/mg of protein as determined by LAL method
-
免疫原
- Respiratory Syncytial Virus F protein
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- RSV (Palivizumab Biosimilar)
-
别名
- Palivizumab Biosimilar
-
物质类
- Biosimilar
抗原
-
You are here:
